Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Efficacy of Intravenous Versus Topical Use of Tranexamic Acid in Reducing Blood Loss After Primary Total Knee Arthroplasty: A Randomized Clinical Trial Publisher



Torkaman A1 ; Rostami A2, 7 ; Sarshar MR3 ; Aghdam HA4, 5 ; Motaghi P6 ; Yazdi H2, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Knee Surgery, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Bone and Joint Reconstruction Research Center, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Orthopedic Surgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Bone and Joint Reconstruction Research Center, Iran University of Medical Sciences, Tehran, Iran
  6. 6. Iran University of Medicals Sciences, Tehran, Iran
  7. 7. Bone and Joint Reconstruction Research Center, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran

Source: Archives of Bone and Joint Surgery Published:2020


Abstract

Background: Blood loss during and immediately after total knee arthroplasty (TKA) is among the most challenging concerns. It has been demonstrated that Tranexamic acid (TXA) can help to reduce perioperative blood loss. TXA can be used as an oral, topical or intravenous injection. Many studies evaluated the effectiveness of each route of administration but few works on a comparison between them. The current study aimed to compare the effectiveness of intravenous injection versus topical use of TXA in reducing perioperative blood loss after primary total knee arthroplasty. Methods: Eighty-five patients who were a candidate for total knee arthroplasty were randomized into two groups: one group received Intravenous injection of 15 mg/kg TXA, 10 min before tourniquet inflation while the other group received 1 g diluted TXA during wound closure. The postoperative blood loss was estimated by measuring the whole drain output and also hemoglobin (HB) drops. Both groups compared based on the need for allogenic blood transfusion and also thromboembolic events. Results: Patients who received topical TXA had a higher total drain output (P<0.0001) compared to intravenous injection. The hemoglobin drop also was more in the topical group although it was marginally significant (P=0.05). Conclusion: Intravenous injection of TXA is more effective in reducing postoperative blood loss after primary TKA compared to topical administration. © BY THE ARCHIVES OF BONE AND JOINT SURGERY.
Experts (# of related papers)
Other Related Docs
9. Prophylactic Effect of Tranexamic Acid on Hemorrhage During and After the Cesarean Section, International Journal of Women's Health and Reproduction Sciences (2019)
10. Does Topical Tranexamic Acid Reduce Postcoronary Artery Bypass Graft Bleeding?, Journal of Research in Medical Sciences (2018)
16. The Effect of Tranexamic Acid on Traumatic Brain Hematomas, Journal of Isfahan Medical School (2016)